| Machine learning directed drug formulation development P Bannigan, M Aldeghi, Z Bao, F Häse, A Aspuru-Guzik, C Allen Advanced Drug Delivery Reviews 175, 113806, 2021 | 126 | 2021 |
| Machine learning models to accelerate the design of polymeric long-acting injectables P Bannigan, Z Bao, RJ Hickman, M Aldeghi, F Häse, A Aspuru-Guzik, ... Nature communications 14 (1), 35, 2023 | 47 | 2023 |
| Turning down the heat: The case for mild hyperthermia and thermosensitive liposomes M Regenold, P Bannigan, JC Evans, A Waspe, MJ Temple, C Allen Nanomedicine: Nanotechnology, Biology and Medicine 40, 102484, 2022 | 35 | 2022 |
| Investigation into the solid and solution properties of known and novel polymorphs of the antimicrobial molecule clofazimine P Bannigan, J Zeglinski, M Lusi, J O’Brien, SP Hudson Crystal Growth & Design 16 (12), 7240-7250, 2016 | 27 | 2016 |
| Role of biorelevant dissolution media in the selection of optimal salt forms of oral drugs: maximizing the gastrointestinal solubility and in vitro activity of the … P Bannigan, E Durack, C Madden, M Lusi, SP Hudson ACS omega 2 (12), 8969-8981, 2017 | 25 | 2017 |
| Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiol LY Kok, P Bannigan, F Sanaee, JC Evans, M Dunne, M Regenold, ... European Journal of Pharmaceutical Sciences 168, 106058, 2022 | 23 | 2022 |
| Face indexing and shape analysis of salicylamide crystals grown in different solvents A Lynch, V Verma, J Zeglinski, P Bannigan, Å Rasmuson CrystEngComm 21 (16), 2648-2659, 2019 | 19 | 2019 |
| Study of three solvates of sulfamethazine D Ahuja, P Bannigan, ÅC Rasmuson CrystEngComm 19 (43), 6481-6488, 2017 | 18 | 2017 |
| The heterogeneous crystallization of a novel solvate of clozapine base in the presence of excipients V Verma, P Bannigan, M Lusi, CM Crowley, S Hudson, BK Hodnett, ... CrystEngComm 20 (31), 4370-4382, 2018 | 17 | 2018 |
| Self-driving laboratories: A paradigm shift in nanomedicine development RJ Hickman, P Bannigan, Z Bao, A Aspuru-Guzik, C Allen Matter 6 (4), 1071-1081, 2023 | 16 | 2023 |
| Revolutionizing drug formulation development: The increasing impact of machine learning Z Bao, J Bufton, RJ Hickman, A Aspuru-Guzik, P Bannigan, C Allen Advanced Drug Delivery Reviews, 115108, 2023 | 12 | 2023 |
| Shifting the paradigm on cannabis safety P Bannigan, JC Evans, C Allen Cannabis and cannabinoid research 7 (1), 3-10, 2022 | 11 | 2022 |
| Delivery of a hydrophobic drug into the lower gastrointestinal system via an endogenous enzyme-mediated carrier mechanism: An in vitro study P Bannigan, E Durack, H Mathur, MC Rea, RP Ross, SP Hudson European Journal of Pharmaceutics and Biopharmaceutics 133, 12-19, 2018 | 11 | 2018 |
| Triggered release from thermosensitive liposomes improves tumor targeting of vinorelbine M Regenold, K Kaneko, X Wang, HB Peng, JC Evans, P Bannigan, ... Journal of Controlled Release 354, 19-33, 2023 | 10 | 2023 |
| Heat-activated nanomedicine formulation improves the anticancer potential of the HSP90 inhibitor luminespib in vitro B Epp-Ducharme, M Dunne, L Fan, JC Evans, L Ahmed, P Bannigan, ... Scientific Reports 11 (1), 11103, 2021 | 9 | 2021 |
| Re-envisioning the design of nanomedicines: harnessing automation and artificial intelligence J Zaslavsky, P Bannigan, C Allen Expert Opinion on Drug Delivery 20 (2), 241-257, 2023 | 7 | 2023 |
| Investigating the effects of amphipathic gastrointestinal compounds on the solution behaviour of salt and free base forms of clofazimine: An in vitro evaluation P Bannigan, K Stokes, A Kumar, C Madden, SP Hudson International Journal of Pharmaceutics 552 (1-2), 180-192, 2018 | 7 | 2018 |
| Atlas: a brain for self-driving laboratories R Hickman, M Sim, S Pablo-García, I Woolhouse, H Hao, Z Bao, ... | 6 | 2023 |
| The impact of endogenous gastrointestinal molecules on the dissolution and precipitation of orally delivered hydrophobic APIs P Bannigan, J Flynn, SP Hudson Expert Opinion on Drug Delivery 17 (5), 677-688, 2020 | 6 | 2020 |
| Overcoming the common ion effect for weakly basic drugs: inhibiting the crystallization of clofazimine hydrochloride in simulated gastrointestinal media P Bannigan, V Verma, SP Hudson Crystal Growth & Design 19 (3), 1599-1609, 2019 | 5 | 2019 |
Christine AllenProfessor and Associate Vice President, Vice-Provost Strategic Initiatives, University of TorontoVerified email at utoronto.ca
